Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10726 - 10750 of 12591 in total
Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2. This strain was isolated from a patient in Wuhan, cultivated in a Vero cell line, and then subsequently inactivated using B-propiolactone. Double-blind, randomized, placebo-controlled phase 1 (96 participants) and phase 2 (224...
Investigational
Matched Description: … strain of SARS-CoV-2. ... Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 ... [A220158] Results from these trials showed low rates of adverse reactions and demonstrated immunogenicity …
Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation. It was studied for the treatment of coronary insufficiency in Italy in the 1970s .
Experimental
Matched Description: … It was studied for the treatment of coronary insufficiency in Italy in the 1970s [A176222]. ... Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation …
Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men).
Investigational
Matched Description: … Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and ... Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and …
AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma.
Investigational
Matched Description: … AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates ... It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma …
A non-metabolizable galactose analog that induces expression of the LAC operon.
Experimental
Matched Description: … A non-metabolizable galactose analog that induces expression of the LAC operon. …
Lersivirine has been used in trials studying the treatment of HIV-1.
Investigational
Matched Description: … Lersivirine has been used in trials studying the treatment of HIV-1. …
Chrysalin has been used in trials studying the treatment of Radius Fracture.
Investigational
Matched Description: … Chrysalin has been used in trials studying the treatment of Radius Fracture. …
Dinitrochlorobenzene has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Dinitrochlorobenzene has been used in trials studying the treatment of HIV Infections. …
Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer. …
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … Talsaclidine has been used in trials studying the treatment of Alzheimer Disease. …
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Description: … BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer. …
Tempol has been used in trials studying the treatment of Anal Cancer.
Investigational
Matched Description: … Tempol has been used in trials studying the treatment of Anal Cancer. …
Mannose is under investigation for the basic science of IUGR and Pregnancy.
Investigational
Matched Description: … Mannose is under investigation for the basic science of IUGR and Pregnancy. …
Merotocin has been used in trials studying the treatment of Preterm Delivery.
Investigational
Matched Description: … Merotocin has been used in trials studying the treatment of Preterm Delivery. …
CPX has been used in trials studying the treatment of Cystic Fibrosis.
Investigational
Matched Description: … CPX has been used in trials studying the treatment of Cystic Fibrosis. …
Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar.
Investigational
Matched Description: … Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar. …
Antimony has been used in trials studying the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Antimony has been used in trials studying the treatment of Cutaneous Leishmaniasis. …
JNJ-38877605 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … JNJ-38877605 has been used in trials studying the treatment of Neoplasms. …
SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.
Investigational
Matched Description: … SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147] …
Edralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.
Investigational
Matched Description: … Edralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase. …
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Matched Description: … SGN-1 is a genetically modified strain of _Salmonella enterica_ comprising methioninase. …
LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
Investigational
Matched Description: … LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor. …
CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
Investigational
Matched Description: … CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen. …
TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Investigational
Matched Description: … TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1. …
AI-128 is the first human demonstration of sustained release drug administration in the lung. AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the lung and how quickly they release their drug.
Investigational
Matched Description: … AI-128 is the first human demonstration of sustained release drug administration in the lung. ... AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the …
Displaying drugs 10726 - 10750 of 12591 in total